Projects per year
Fingerprint
Dive into the research topics where Ph. D. Program in the Clinical Drug Development of Herbal Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Wei-Chiao Chang
- Department of Clinical Pharmacy - Professor
- Master Program in Applied Epidemiology - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- The Ph.D. Program for Translational Medicine - Joint-Appointment Professor
- Ph.D. Program in Medical Neuroscience - Joint-Appointment Professor
- TMU Research Center of Cancer Translational Medicine - Member
- TMU Research Center of Cell Therapy and Regeneration Medicine - member
Person: Researcher
-
Mei-Chuan Chen
- Department of Pharmaceutical Sciences - Professor
- Graduate Institute of Pharmacognosy - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- TMU Research Center of Thoracic Medicine - Member
Person: Researcher
-
Yu-Wen Cheng
- Department of Pharmaceutical Sciences - Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Department of Ophthalmology - Joint-Appointment Professor
- TMU Research Center of Drug Discovery - Member
- TMU Research Center of Neuroscience - Member
Person: Researcher
-
Discovery of Bbb-Crossing Drugs Targeting Neuroinflammation for Glioblastoma( III )
Liou, J.-P. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
以化學分子網絡探索海洋藥用資源：台灣海綿活性代謝組成資料庫之建立與應用(1/3)
Lai, K.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Establishing Anti-Inflammatory Metabolomic Database of Tcms Using Chemical Molecular Networking Approach
Lai, K.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
2-Hydroxyl hispolon reverses high glucose-induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO-1 pathways
Wang, T. J., Hou, W. C., Hsiao, B. Y., Lo, T. H., Chen, Y. T., Yang, C. H., Shih, Y. T. & Liu, J. C., 2025, (Accepted/In press) In: British Journal of Pharmacology.Research output: Contribution to journal › Article › peer-review
Open Access -
Activation of the Trichodimerol Pathway through Deletion of mcrA in Marine Penicillium rubens YAP001
Shyong, J., Tran Huynh, Q. D., Dziedzic, S., Aguirre, E., Rabot, C., Yuan, B., Herrero-MacKenzie, H. E., Stajich, J. E., Lee, C. K., Kenkel, C. D. & Wang, C. C. C., 2025, (Accepted/In press) In: ACS Chemical Biology. 20, 4, p. 823-829 7 p.Research output: Contribution to journal › Article › peer-review
-
Advancing glioblastoma therapy: Learning from the past and innovations for the future
Rana, M., Liou, K. C., Thakur, A., Nepali, K. & Liou, J. P., May 1 2025, In: Cancer Letters. 617, 217601.Research output: Contribution to journal › Article › peer-review
Datasets
-
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4522856.v1, https://springernature.figshare.com/collections/Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/4522856/1
Dataset
-
Additional file 4: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202896.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202896/1
Dataset
-
Additional file 1 of Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Liu, E.-S. (Contributor), Wang, C.-K. (Contributor), Chuang, K.-H. (Contributor), Chen, F.-M. (Creator), Wu, T.-H. (Contributor), Chen, C.-Y. (Creator), Chen, I.-J. (Creator), Lin, R.-A. (Creator), Wang, Y.-M. (Contributor), Lu, Y.-C. (Contributor), Liao, T.-Y. (Contributor), Chen, H.-J. (Creator), Cheng, T.-L. (Creator) & Cheng, Y.-A. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12885938.v1, https://doi.org/10.6084%2Fm9.figshare.12885938.v1
Dataset